Page 1099 - Hall et al (2015) Principles of Critical Care-McGraw-Hill
P. 1099

2      References


                   27. Gregg CR, Nassar NN. Infectious Enteritis. Curr Treat Options   responsible for a nosocomial outbreak of Clostridium difficile-
                      Gastroenterol. 1999;2(2):119-126.                      associated diarrhea. J Clin Microbiol. 2000;38(7):2706-2714.
                   28. Cohen SH, Gerding DN, Johnson S, et al. Clinical practice     39. Tabibian N. Diarrhea in critically ill patients. Am Fam Physician.
                      guidelines for Clostridium difficile infection in adults: 2010   1989;40(2):135-140.
                      update by the society for healthcare epidemiology of America     40. George WL, Rolfe RD, Harding GK, Klein R, Putnam CW,
                      (SHEA) and the infectious diseases society of America (IDSA).   Finegold SM. Clostridium difficile and cytotoxin in feces of
                      Infect Control Hosp Epidemiol. 31(5):431-455.          patients with antimicrobial agent-associated pseudomembra-
                   29. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs   nous colitis. Infection. 1982;10(4):205-208.
                      and mortality associated with nosocomial diarrhea due to     41. Schmidt ML, Gilligan PH. Clostridium difficile test-
                      Clostridium difficile. Clin Infect Dis. 2002;34(3):346-353.  ing algorithms: what is practical and feasible?  Anaerobe.
                   30. O’Brien JA, Lahue BJ, Caro JJ, Davidson DM. The emerging   2009;15(6):270-273.
                      infectious challenge of clostridium difficile-associated dis-    42. Reller ME, Lema CA, Perl TM, et al. Yield of stool culture with
                      ease in Massachusetts hospitals: clinical and economic conse-  isolate toxin testing versus a two-step algorithm including stool
                      quences. Infect Control Hosp Epidemiol. 2007;28(11):1219-1227.  toxin testing for detection of toxigenic Clostridium difficile.
                   31. Leclair MA, Allard C, Lesur O, Pepin J. Clostridium difficile   J Clin Microbiol. 2007;45(11):3601-3605.
                      infection in the intensive care unit.  J Intensive Care Med.     43. Teasley DG, Gerding DN, Olson MM, et al. Prospective
                      25(1):23-30.                                           randomised trial of metronidazole versus vancomycin for
                   32. McDonald LC, Killgore GE, Thompson A, et al. An epidemic,   Clostridium-difficile-associated diarrhoea and colitis.  Lancet.
                      toxin gene-variant strain of Clostridium difficile. N Engl J Med.   1983;2(8358):1043-1046.
                      2005;353(23):2433-2441.                             44. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A com-
                   33. Labbe AC, Poirier L, Maccannell D, et al. Clostridium difficile   parison of vancomycin and metronidazole for the treatment of
                      infections in a Canadian tertiary care hospital before and dur-  Clostridium difficile-associated diarrhea, stratified by disease
                      ing a regional epidemic associated with the BI/NAP1/027 strain.   severity. Clin Infect Dis. 2007;45(3):302-307.
                      Antimicrob Agents Chemother. 2008;52(9):3180-3187.    45. Friedenberg F, Fernandez A, Kaul V, Niami P, Levine GM.
                   34. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial   Intravenous  metronidazole  for  the  treatment  of  Clostridium
                      acquisition of Clostridium difficile infection.  N Engl J Med.   difficile colitis. Dis Colon Rectum. 2001;44(8):1176-1180.
                      1989;320(4):204-210.                                46. Fekety R. Guidelines for the diagnosis and management of
                   35. Samore MH, DeGirolami PC, Tlucko A, Lichtenberg DA,   Clostridium difficile-associated diarrhea and colitis. American
                      Melvin ZA, Karchmer AW. Clostridium difficile coloniza-  College of Gastroenterology, Practice Parameters Committee.
                      tion and diarrhea at a tertiary care hospital.  Clin Infect Dis.   Am J Gastroenterol. 1997;92(5):739-750.
                      1994;18(2):181-187.                                 47. Bartlett JG. Clinical practice. Antibiotic-associated diarrhea.
                   36. Vaishnavi C. Established and potential risk factors for Clostridum   N Engl J Med. 2002;346(5):334-339.
                      difficile infection. Indian J Med Microbiol. 2009;27(4):289-300.    48. Pillai A, Nelson R. Probiotics for treatment of Clostridium
                   37. Poxton IR, McCoubrey J, Blair G. The pathogenicity of   difficile-associated colitis in adults. Cochrane Database Syst Rev.
                      Clostridium difficile. Clin Microbiol Infect. 2001;7(8):421-427.  2008(1):CD004611.
                   38. Alfa MJ, Kabani A, Lyerly D, et al. Characterization of a toxin     49. Morrow LE. Probiotics in the intensive care unit. Curr Opin Crit
                      A-negative, toxin B-positive strain of Clostridium difficile   Care. 2009;15(2):144-148.








































            Section05-O-ref.indd   2                                                                                   1/20/2015   4:51:24 PM
   1094   1095   1096   1097   1098   1099   1100   1101   1102   1103   1104